{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T08:52:20Z","timestamp":1773564740968,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":4389,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.ymthe.2004.06.1013","type":"journal-article","created":{"date-parts":[[2004,8,5]],"date-time":"2004-08-05T19:44:01Z","timestamp":1091735041000},"page":"792-798","source":"Crossref","is-referenced-by-count":62,"title":["Physical and infectious titers of helper-dependent adenoviral vectors: a method of direct comparison to the adenovirus reference material"],"prefix":"10.1016","volume":"10","author":[{"given":"Donna J.","family":"Palmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2004.06.1013_bib1","first-page":"291","article-title":"Replicating adenoviruses in cancer therapy","volume":"273","author":"Dobbelstein","year":"2004","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ymthe.2004.06.1013_bib2","series-title":"Vaccines: New Approaches to Immunological Problems","first-page":"363","article-title":"Adenovirus-based expression vectors and recombinant vaccines","author":"Graham","year":"1992"},{"key":"10.1016\/j.ymthe.2004.06.1013_bib3","series-title":"Gene Therapy: Therapeutic Mechanisms and Strategies","first-page":"53","article-title":"Helper-dependent adenoviral vectors for gene therapy","author":"Ng","year":"2003"},{"key":"10.1016\/j.ymthe.2004.06.1013_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0042-6822(68)90121-9","article-title":"The polypeptides of adenovirus. I. Evidence of multiple protein components in the virion and a comparison of types 2, 7a, and 12","volume":"36","author":"Maizel","year":"1968","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2004.06.1013_bib5","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/JVI.70.11.7498-7509.1996","article-title":"Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy","volume":"70","author":"Mitterder","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.06.1013_bib6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/viro.2002.1406","article-title":"Evaluation of accuracy and precision of adenovirus absorptivity at 260 nm under conditions of complete DNA disruption","volume":"295","author":"Sweeny","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2004.06.1013_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.12665\/J13.Simek","article-title":"FDA perspective on the use of the adenovirus reference material","volume":"1","author":"Simek","year":"2002","journal-title":"BioProcessing"},{"key":"10.1016\/j.ymthe.2004.06.1013_bib8","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm0797-808","article-title":"Sensitivity and reproducibility in adenoviral infectious titer determination","volume":"3","author":"Nyberg-Hoffman","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2004.06.1013_bib9","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1089\/10430349950018364","article-title":"Adenoviral gene therapy leads to rapid induction of multiple cytokines and acute neutrophil-dependent hepatic injury in vivo","volume":"10","author":"Muruve","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.06.1013_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1006\/mthe.2001.0329","article-title":"Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages","volume":"3","author":"Zhang","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2004.06.1013_bib11","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1006\/mthe.2001.0330","article-title":"Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors","volume":"3","author":"Schnell","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2004.06.1013_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/10430340460732445","article-title":"Acute toxicity following high-dose systemic injection of helper-dependent adenoviral vectors into non human primates","volume":"15","author":"Brunetti-Pierri","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.06.1013_bib13","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1128\/JVI.78.11.5966-5972.2004","article-title":"Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo","volume":"78","author":"Muruve","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.06.1013_bib14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1006\/mthe.2000.0217","article-title":"Working towards an adenoviral vector testing standard","volume":"2","author":"Hutchins","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2004.06.1013_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/10837459809009865","article-title":"Factors that influence stability of recombinant adenoviral preparations for human gene therapy","volume":"3","author":"Croyle","year":"1998","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ymthe.2004.06.1013_bib16","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/11400","article-title":"Instability of adenoviral vectors during transport and its implication for clinical studies","volume":"5","author":"Nyberg-Hoffman","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2004.06.1013_bib17","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.gt.3301527","article-title":"Development of formulations that enhance physical stability of viral vectors for gene therapy","volume":"8","author":"Croyle","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2004.06.1013_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/mthe.2001.0411","article-title":"Development of novel formulations that enhance adenoviral-mediated gene expression in the lung in vitro and in vivo","volume":"4","author":"Croyle","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2004.06.1013_bib19","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1128\/JVI.67.10.5911-5921.1993","article-title":"Packaging capacity and stability of human adenovirus type 5 vectors","volume":"67","author":"Bett","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.06.1013_bib20","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1128\/JVI.71.4.3293-3298.1997","article-title":"A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging","volume":"71","author":"Parks","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.06.1013_bib21","first-page":"371","article-title":"Methods for the preparation of helper-dependent adenoviral vectors","volume":"69","author":"Ng","year":"2002","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.ymthe.2004.06.1013_bib22","first-page":"1","article-title":"Assessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee","volume":"13","author":"NIH","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.06.1013_bib23","doi-asserted-by":"crossref","first-page":". 148","DOI":"10.1016\/j.ymgme.2003.08.016","article-title":"Fatal systemic inflammatory response syndrome in an ornithine transcarbamylase deficient patient following adenoviral gene transfer","volume":"80","author":"Raper","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2004.06.1013_bib24","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1128\/JVI.76.9.4181-4189.2002","article-title":"Cre levels limit packaging signal excision efficiency in the Cre\/loxP helper-dependent adenoviral vector system","volume":"76","author":"Ng","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.06.1013_bib25","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1182\/blood.V99.11.3923","article-title":"A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivo","volume":"99","author":"Ehrhardt","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.06.1013_bib26","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1089\/104303402320138934","article-title":"A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparations","volume":"13","author":"Kreppel","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.06.1013_bib27","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ymthe.2003.08.014","article-title":"Improved system for helper-dependent adenovirus vector production","volume":"8","author":"Palmer","year":"2003","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001604013085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001604013085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T23:06:34Z","timestamp":1585868794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001604013085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S1525001604013085"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2004.06.1013","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}